BERYL DRUGS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Beryl Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.81₹ 0.88
As on Nov 7, 2025, 4:01 PM IST
Beryl Drugs Price Performance
Today's LowToday's High
₹23.10₹23.98
₹23.98
52 Weeks' Low52 Weeks' High
₹17.35₹43.70
₹23.98
Open Price
₹23.10
Prev. Close
₹23.10
Volume
118
Over the last 5 years, the share price of Beryl Drugs has gained 30.36% CAGR. Over the past year, the corresponding return has been -36.99%.
Beryl Drugs’s current P/E of 7.82x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Beryl Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Beryl Drugs | -0.21 | 5.41 | 21.54 | 28.72 | -36.99 | 34.34 | 30.36 |
| Sun Pharmaceutical Industries | 0.17 | 2.32 | 5.89 | -4.97 | -5.51 | 18.09 | 27.12 |
| Divi's Laboratories | -1.33 | 9.09 | 8.54 | 8.33 | 11.71 | 24.93 | 14.22 |
| Cipla | 0.19 | -0.62 | 0.88 | -0.30 | -4.38 | 9.97 | 14.56 |
| Torrent Pharmaceuticals | 0.45 | 0.90 | -0.61 | 8.67 | 13.15 | 28.64 | 22.91 |
| Dr. Reddy's Laboratories | 0.63 | -3.51 | 0.38 | 3.90 | -6.36 | 10.34 | 4.32 |
| Zydus Lifesciences | -3.15 | -4.45 | -0.16 | 6.43 | -2.96 | 27.92 | 16.65 |
| Mankind Pharma | -5.00 | -8.82 | -10.96 | -6.86 | -16.99 | 16.70 | 9.71 |
| Lupin | 0.34 | 2.40 | 1.26 | -4.83 | -6.62 | 40.55 | 16.52 |
| Alkem Laboratories | 3.04 | 3.38 | 16.32 | 12.75 | -0.82 | 20.74 | 15.42 |
| Aurobindo Pharma | -1.38 | 3.05 | 5.01 | -6.19 | -16.85 | 26.32 | 7.37 |
| Abbott India | -0.61 | -3.43 | -12.03 | -4.74 | 1.89 | 14.26 | 13.16 |
| Laurus Labs | 3.06 | 13.99 | 17.36 | 61.16 | 98.76 | 28.45 | 30.06 |
| Glenmark Pharmaceuticals | -3.46 | -7.00 | -11.55 | 27.12 | 10.09 | 62.80 | 30.55 |
| Biocon | 2.19 | 9.22 | 4.26 | 9.68 | 15.85 | 10.97 | -1.75 |
| GlaxoSmithKline Pharmaceuticals | -1.28 | -5.42 | -3.31 | -9.03 | -0.75 | 24.59 | 12.94 |
| Anthem Biosciences | -1.65 | -10.11 | -6.90 | -4.34 | -4.34 | -1.47 | -0.88 |
| Ipca Laboratories | 3.32 | -3.34 | -5.49 | -3.64 | -15.61 | 13.23 | 3.03 |
| Ajanta Pharma | 2.50 | 2.60 | -3.44 | 1.14 | -15.38 | 26.54 | 19.21 |
| Gland Pharma | -3.34 | -3.85 | -4.71 | 32.89 | 3.22 | 1.03 | 0.48 |
Over the last one year, Beryl Drugs has declined 36.99% compared to peers like Sun Pharmaceutical Industries (-5.51%), Divi's Laboratories (11.71%), Cipla (-4.38%). From a 5 year perspective, Beryl Drugs has outperformed peers relative to Sun Pharmaceutical Industries (27.12%) and Divi's Laboratories (14.22%).
Beryl Drugs Financials
Beryl Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 23.44 | 23.33 |
| 10 | 23.3 | 23.31 |
| 20 | 23.13 | 23.23 |
| 50 | 23.51 | 22.98 |
| 100 | 22.01 | 22.91 |
| 200 | 23.81 | 24.29 |
Beryl Drugs Share Holding Pattern
In the latest quarter, Beryl Drugs remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 73.62% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Beryl Drugs Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 06, 2025, 1:41 AM IST | Beryl Drugs Ltd. - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30 |
| Oct 08, 2025, 3:27 AM IST | Beryl Drugs Ltd. - Compliance-57 (5) : intimation after the end of quarter |
| Oct 07, 2025, 8:06 PM IST | Beryl Drugs Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 02, 2025, 9:21 PM IST | Beryl Drugs Ltd. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 30, 2025, 10:03 PM IST | Beryl Drugs Ltd. - APPOINTMENT OF MRS. DIPIKA KATARIA AS SECRETARIAL AUDITOR OF THE COMPANY FOR A PERIOD OF FIVE YEARS |
About Beryl Drugs
Beryl Drugs Ltd. is a Public Limited Listed company incorporated on 24/08/1993 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L02423MP1993PLC007840 and registration number is 007840. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 21.15 Cr. and Equity Capital is Rs. 5.09 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address133, Kanchan Bagh, Indore Madhya Pradesh 452001
- Contact
Management
- Mr. Sudhir SethiChairman & Director
- Mr. Sanjay SethiManaging Director
- Mr. Abhinav NaikIndependent Director
- Mrs. Shreya SarafIndependent Woman Director
FAQs on Beryl Drugs Share Price
What is the share price of Beryl Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Beryl Drugs is ₹23.98 as on Nov 07, 2025.
What kind of stock is Beryl Drugs?
The Beryl Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Beryl Drugs?
The market cap of Beryl Drugs is ₹12.16 Cr as on Nov 07, 2025.
What are today's High and Low prices of Beryl Drugs?
Today’s highest and lowest price of Beryl Drugs are ₹23.98 and ₹23.10.
What are the 52 Week High and 52 Week Low of Beryl Drugs?
The 52-week high/low is the highest and lowest price at which Beryl Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Beryl Drugs is ₹43.70 and 52-week low of Beryl Drugs is ₹17.35 as on Nov 07, 2025.
How has the Beryl Drugs performed historically in terms of returns?
The Beryl Drugs has shown returns of 3.81% over the past day, 5.41% for the past month, 21.54% over 3 months, -36.99% over 1 year, 34.34% across 3 years, and 30.36% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Beryl Drugs?
P/E ratio of and PB ratio of Beryl Drugs are 7.82 and 2.01 on Nov 07, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse